Significados de largest biotechnology em inglês

The world's largest biotechnology company said Nanula, 46, was leaving to pursue other opportunities.

A spokeswoman for Amgen, the world's largest biotechnology company, declined to comment on the report.

Amgen, the world's largest biotechnology company, is still widely considered to be the front-runner to acquire Onyx.

The acquisition - which ends a two-month-long auction of Onyx - represents the fifth- largest biotechnology deal in history.

AMGEN, THE world's largest biotechnology company, is in advanced talks to acquire a Dublin operation of rival Pfizer.

Shares of Amgen Inc AMGN.O rose after the world's largest biotechnology company by sales said fourth-quarter profit edged higher.

Amgen Inc AMGN.O helped curb the Nasdaq's decline after the world's largest biotechnology company reported a better-than-expected profit on Wednesday.

Amgen, the world's largest biotechnology company, stopped the trial for safety reasons after discovering its drug Vectibix reduced chances of survival.

The announcement marks a coup for IDA Ireland, which has targeted an investment from the world's largest biotechnology group for several years.

Amgen, the world's largest biotechnology company, said it intends to cooperate fully with the informal request from the SEC's Atlanta district office.

Spokesman David Polk said he did not expect Amgen, the world's largest biotechnology company, to issue financial forecasts at the New York meeting.

A deal, which is still being finalized and would require board approval from both companies, would represent the fifth- largest biotechnology deal in history.

The world's second- largest biotechnology company pushed up the date of the meeting with analysts and investors after recommending shareholders reject Roche's tender offer.

The fund also significantly increased holdings in Amgen Inc AMGN.O, the world's largest biotechnology company, due to an improving outlook for the company.

But Aranesp is by far Amgen's biggest product and, along with Epogen, accounts for roughly half of the world's largest biotechnology company's profit.

Shares of the world's largest biotechnology company rose 2.56 percent to close at $62.81 on Nasdaq.